These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 32543949)
1. Relapse prevention in panic disorder with pharmacotherapy: where are we now? Caldirola D; Alciati A; Daccò S; Micieli W; Perna G Expert Opin Pharmacother; 2020 Oct; 21(14):1699-1711. PubMed ID: 32543949 [No Abstract] [Full Text] [Related]
2. Are there advances in pharmacotherapy for panic disorder? A systematic review of the past five years. Caldirola D; Alciati A; Riva A; Perna G Expert Opin Pharmacother; 2018 Aug; 19(12):1357-1368. PubMed ID: 30063164 [TBL] [Abstract][Full Text] [Related]
3. Three year naturalistic outcome study of panic disorder patients treated with paroxetine. Dannon PN; Iancu I; Cohen A; Lowengrub K; Grunhaus L; Kotler M BMC Psychiatry; 2004 Jun; 4():16. PubMed ID: 15191617 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy and tolerability of escitalopram in anxiety disorders: a review]. Pelissolo A Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243 [TBL] [Abstract][Full Text] [Related]
5. Rational treatment of panic disorder with antidepressants. Mavissakalian MR; Ryan MT Ann Clin Psychiatry; 1998 Dec; 10(4):185-95. PubMed ID: 9988061 [TBL] [Abstract][Full Text] [Related]
11. [Panic disorder: clinical phenomena and treatment options]. Sivolap YP Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(4):112-116. PubMed ID: 28617392 [TBL] [Abstract][Full Text] [Related]
12. Evidence-based pharmacotherapy of panic disorder: an update. Batelaan NM; Van Balkom AJ; Stein DJ Int J Neuropsychopharmacol; 2012 Apr; 15(3):403-15. PubMed ID: 21733234 [TBL] [Abstract][Full Text] [Related]
13. Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies. Mochcovitch MD; Nardi AE Expert Rev Neurother; 2010 Aug; 10(8):1285-93. PubMed ID: 20662754 [TBL] [Abstract][Full Text] [Related]
14. Venlafaxine treatment of panic disorder: a case series. Geracioti TD J Clin Psychiatry; 1995 Sep; 56(9):408-10. PubMed ID: 7665539 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. Simon NM; Safren SA; Otto MW; Sharma SG; Lanka GD; Pollack MH J Affect Disord; 2002 May; 69(1-3):201-8. PubMed ID: 12103467 [TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of panic disorder: proposed guidelines for the family physician. Roy-Byrne P; Stein M; Bystrisky A; Katon W J Am Board Fam Pract; 1998; 11(4):282-90. PubMed ID: 9719350 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological approaches to the management of panic disorder in older patients: a systematic review. Caldirola D; De Donatis D; Alciati A; Daccò S; Perna G Expert Rev Neurother; 2023; 23(11):1013-1029. PubMed ID: 37676054 [TBL] [Abstract][Full Text] [Related]
18. The side effect burden associated with drug treatment of panic disorder. Baldwin DS; Birtwistle J J Clin Psychiatry; 1998; 59 Suppl 8():39-44; discussion 45-6. PubMed ID: 9707161 [TBL] [Abstract][Full Text] [Related]
19. Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors. Kasper S; Resinger E Eur Neuropsychopharmacol; 2001 Aug; 11(4):307-21. PubMed ID: 11532386 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder:a randomized controlled trial. Rosenthal JZ; Boyer P; Vialet C; Hwang E; Tourian KA J Clin Psychiatry; 2013 Feb; 74(2):158-66. PubMed ID: 23473348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]